ProPhase Labs, Inc. Property, Plant and Equipment, Gross
ProPhase Labs, Inc. (PRPH) had Property, Plant and Equipment, Gross of $15.73 million as of 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Balance Sheet › Assets › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2023-03-29
- 2022-12-31: Property, Plant and Equipment, Gross $15.73M.
- 2022-09-30: Property, Plant and Equipment, Gross $13.98M.
- 2022-06-30: Property, Plant and Equipment, Gross $13.82M.
- 2022-03-31: Property, Plant and Equipment, Gross $13.81M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2022-12-31 | $15.73M 10-K · filed 2023-03-29 |
| 2022-09-30 | $13.98M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $13.82M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $13.81M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $12.83M 10-K · filed 2023-03-29 |
| 2021-09-30 | $12.86M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $12.84M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $12.53M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $8.60M 10-K · filed 2022-03-31 |
| 2020-09-30 | $7.02M 10-Q · filed 2020-11-19 |
| 2020-06-30 | $8.51M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $8.66M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $8.58M 10-K · filed 2021-03-31 |
| 2019-09-30 | $8.54M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $8.43M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $8.40M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $8.35M 10-K · filed 2020-03-26 |
| 2017-12-31 | $8.21M 10-K · filed 2019-03-26 |
| 2016-12-31 | $8.31M 10-K/A · filed 2018-08-20 |
| 2015-12-31 | $7.66M 10-K · filed 2017-02-24 |
| 2014-12-31 | $6.94M 10-K · filed 2016-03-29 |
| 2013-12-31 | $6.63M 10-K · filed 2015-03-27 |
| 2012-12-31 | $6.22M 10-K · filed 2014-03-27 |
| 2011-12-31 | $5.92M 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |